Literature DB >> 3365547

Remote memory function in Alzheimer's disease and Parkinson's disease.

H J Sagar1, N J Cohen, E V Sullivan, S Corkin, J H Growdon.   

Abstract

Remote memory for public and personal events was evaluated in Alzheimer's disease (AD) and Parkinson's disease (PD), using a series of recall and recognition tests. Information related to content and date of past events was assessed separately. In recall of the content of personal and public events, both groups showed a gradient of deficit in which remote events were affected less than recent ones; the magnitude and temporal extent of the retrograde loss was related to severity of dementia. By contrast, gradient effects were not evident in the recall of date and were less marked in the recognition of content or date. In public and personal events tests, patients with PD showed a relative impairment in dating capacity, compared with their memory for the content of events, which was independent of dementia. These results suggest that dementia affects the recall of distant events less than recall of recent ones. Furthermore, the selective gradient effects in recall of content suggest that memory for date is served by cognitive processes independent of memory for event content. In PD, dating capacity is a sensitive measure of remote memory function that may be disrupted independently of dementia.

Entities:  

Mesh:

Year:  1988        PMID: 3365547     DOI: 10.1093/brain/111.1.185

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  20 in total

Review 1.  Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease.

Authors:  M Simard; R van Reekum
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

2.  Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease.

Authors:  I Litvan; E Mohr; J Williams; C Gomez; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

3.  Episodic simulation of future events is impaired in mild Alzheimer's disease.

Authors:  Donna Rose Addis; Daniel C Sacchetti; Brandon A Ally; Andrew E Budson; Daniel L Schacter
Journal:  Neuropsychologia       Date:  2009-06-02       Impact factor: 3.139

4.  Cognitive functioning after pallidotomy for refractory Parkinson's disease.

Authors:  K Perrine; M Dogali; E Fazzini; D Sterio; E Kolodny; D Eidelberg; O Devinsky; A Beric
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

Review 5.  Neuropsychological aspects of Parkinson's disease.

Authors:  S A Raskin; J C Borod; J Tweedy
Journal:  Neuropsychol Rev       Date:  1990-09       Impact factor: 7.444

6.  Impairment in dating and retrieving remote events in patients with early Parkinson's disease.

Authors:  A Venneri; P Nichelli; G Modonesi; M A Molinari; R Russo; C Sardini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

Review 7.  Consolidation theory and retrograde amnesia in humans.

Authors:  Alan S Brown
Journal:  Psychon Bull Rev       Date:  2002-09

8.  Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction.

Authors:  T W Robbins; M James; A M Owen; K W Lange; A J Lees; P N Leigh; C D Marsden; N P Quinn; B A Summers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

Review 9.  Memory loss in Alzheimer's disease: implications for development of therapeutics.

Authors:  Carl A Gold; Andrew E Budson
Journal:  Expert Rev Neurother       Date:  2008-12       Impact factor: 4.618

10.  Recognition of famous names predicts cognitive decline in healthy elders.

Authors:  Michael Seidenberg; Christina D Kay; John L Woodard; Kristy A Nielson; J Carson Smith; Cassandra Kandah; Leslie M Guidotti Breting; Julia Novitski; Melissa Lancaster; Monica Matthews; Nathan Hantke; Alissa Butts; Stephen M Rao
Journal:  Neuropsychology       Date:  2013-05       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.